Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Xyrem
Pharma
Jazz Pharma settles Xyrem antitrust claims for $145M
The company settled with several purchaser plaintiffs in an antitrust case that involved Jazz and generic Xyrem maker Hikma Pharmaceuticals.
Zoey Becker
Apr 10, 2025 8:50am
After trial win, Axsome eyes FDA filing for narcolepsy hopeful
Nov 27, 2024 9:46am
Jazz Pharma, focused on launches, reveals some exec changes
Sep 12, 2023 1:55pm
FDA faces lawsuit from Jazz after approval of Avadel's sleep aid
Jun 23, 2023 11:38am
The top 10 drug patent expirations of 2023
Mar 13, 2023 3:00am
In Jazz case, FTC urges court to delist patent on Xyrem
Nov 14, 2022 9:40am
